Page 248 - 2021_06-Haematologica-web

Letters to the Editor
7.CastroO,SandlerSG,Houston-YuP,RanaS.Predictingtheeffectof transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion. 2002;42(6):684-690.
8. Karafin MS, Field JJ, Gottschall JL, Denomme GA. Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease. Transfusion. 2015;55(6):1399-1406.
9. Yee ME, Josephson CD, Winkler AM, et al. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia. Transfusion. 2017;57(11):2738-2746.
10.Campbell-Lee SA, Gvozdjan K, Choi KM, et al. Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods. Transfusion. 2018;58(7):1588- 1596.
11. Miller ST, Kim H-Y, Weiner DL, et al. Red blood cell alloimmuniza-
tion in sickle cell disease: prevalence in 2010. Transfusion.
2013;53(4):704-709.
12. Coleman S, Westhoff CM, Friedman DF, Chou ST.
Alloimmunization in patients with sickle cell disease and under- recognition of accompanying delayed hemolytic transfusion reac- tions. Transfusion. 2019;59(7):2282-2291.
13. Chou ST, Evans P, Vege S, et al. RH genotype matching for transfu- sion support in sickle cell disease. Blood. 2018;132(11):1198-1207. 14. Floch A, Gien D, Tournamille C, et al. High immunogenicity of red
blood cell antigens restricted to the population of African descent in a cohort of sickle cell disease patients. Transfusion. 2018;58(6):1527- 1535.
15.HarmSK,YazerMH,MonisGF,TriulziDJ,AubuchonJP,DelaneyM. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. Am J Clin Pathol. 2014;141(2):256-261.
2276
haematologica | 2021; 106(8)